×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe ...
PR Newswire
PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients...
4 days ago
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
Yahoo Finance
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings...
1 day ago
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe ...
The Globe and Mail
Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.
18 hours ago
Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) First Quarter 2024 Results Key Financial Results Revenue: US$494.3m (up 55...
2 days ago
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
Business Wire
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for...
2 days ago
News - bempegaldesleukin, Alnylam Pharmaceuticals
The Pharma Letter
The week in pharma: action, reaction and insight – week to March 18, 2022. 20-03-2022. Regulatory news last week included the US Food and Drug...
2 days ago
Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance
Alnylam Pharmaceuticals (ALNY) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.75.
2 days ago
Experts paint tough path ahead of Alnylam's key ATTR-CM readout
Fierce Pharma
As a closely watched readout from Alnylam Pharmaceuticals' Amvuttra in the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM)...
2 weeks ago
Citigroup Maintains Alnylam Pharmaceuticals (ALNY) Buy Recommendation
MSN
Fintel reports that on August 4, 2023, Citigroup maintained coverage of Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy recommendation.
2 days ago
Alnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Yahoo Finance
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) First Quarter 2024 Results Key Financial Results Revenue: US$494.3m (up 55...
1 day ago